HPN328, Harpoon’s DLL3-targeting T cell engager, to be evaluated in combination with anti-PD-L1 antibody in patients with small cell lung…
LAS VEGAS, NV, May 02, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Digipath, Inc. (OTCQB: DIGP) (“Digipath” or the “Company”),…
Beverly Hills, May 02, 2022 (GLOBE NEWSWIRE) -- While studying for her Doctor of Dental Surgery degree at the University…
Company to host conference call and webcast at 5:00 p.m. ETMENLO PARK, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- CohBar,…
BrainsWay will donate $5 per share, $2 per comment, and $1 per like to support the work of Mental Health AmericaBURLINGTON,…
Leading medical technology company recognized for employee engagement and culturePALM BEACH GARDENS, Fla., May 02, 2022 (GLOBE NEWSWIRE) -- Accelus,…
TEL AVIV, Israel, May 02, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ: SPRC), a specialty clinical-stage pharmaceutical company focusing on…
Phase 3 study of LB1148 in lead indication for postoperative return of bowel function on track to commence Q2 2022CARLSBAD, Calif.,…
Whitney Johns Product Line The New Whitney Johns Product Line includes BRAIN ACTIVATE (in gel and powder form), ACTIVE for…
First-in-human non-viral TCR-T cell therapy targeting shared hotspot mutations in solid cancersFirst clinical product manufactured and administered to a patient…